Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024)

Guided Therapeutics (GTHP) reported Dividends Paid - Common of $54824.0 for Q2 2024, down 16.04% sequentially from $65296.0 in Q1 2024.

Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024) Analysis & Trends

Guided Therapeutics (GTHP) has 2 years of Dividends Paid - Common data on file, last reported at $54824.0 in Q2 2024.

For the quarter ending Q2 2024, Dividends Paid - Common changed N/A year-over-year to $54824.0; the trailing twelve-month figure through Jun 2024 stood at $120120.0 (up 83.96% YoY), and the FY2023 full-year result was $65296.0, down 45.64% from the prior year.
Dividends Paid - Common retreated to $54824.0 in Q2 2024, from $65296.0 in the prior quarter.
In the past five years, Dividends Paid - Common ranged from a high of $65296.0 in Q1 2023 to a low of $54824.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends Paid - Common (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	1.10 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	337.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	908.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-1.17 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	16.00 Mn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Guided Therapeutics	21.96 Mn	21.89 Mn	458,000.00	-

Download Data